# Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin

> **NCT05593601** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 60 (estimated)

## Conditions studied

- Colonization, Asymptomatic

## Interventions

- **DRUG:** Neomycin

## Key facts

- **NCT ID:** NCT05593601
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-24
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05593601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05593601, "Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05593601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*